Skip to main content

Table 2 ETV5 expression and clinicopathological parameters

From: Biological and prognostic value of ETV5 in high-grade serous ovarian cancer

Characteristies

n

ETV5 expression

χ2

P

 

87

Over expression (%)

Low expression (%)

  

Age

 < 55

44

20(45.5)

24(54.5)

4.587

0.032**

 ≥55

43

32(74.4)

11(25.6)

  

FIGO stage

 I-II

21

12(57.1)

9(42.9)

4.212

0.040*

 III-IV

66

40(60.6)

26(39.4)

  

Chemotherapy response

 sensitive

26

10(38.5)

16(61.5)

6.502

0.011*

 partial

24

16(66.7)

8(33.3)

  

 unknown

37

    

Recurrence

 No

27

14(51.9)

13(48.1)

0.979

0.322

 Yes

10

7(70.0)

3(30.0)

  

 unknown

50

    

Ascites

 No

26

15(57.7)

11(42.3)

0.201

0.654

 Yes

61

32(52.5)

29(47.5)

 Â